Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
JEOL Ltd. (6951.T)
Akishima, JP
JEOL Ltd. is dedicated to the innovation, production, and global distribution of a broad spectrum of advanced technology, covering scientific and metrology instruments, semiconductor and industrial equipment, and medical devices. Their comprehensive array of scientific tools includes transmission and scanning electron microscopes, along with ion beam application systems utilized for specimen preparation and multibeam operations. They also offer specialized instruments for micro area and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers. Moreover, their portfolio features magnetic resonance equipment, like nuclear magnetic resonance (NMR) and electron spin resonance (ESR) spectrometers, as well as X-ray fluorescence spectrometers, mass spectrometers, and electron beam lithography systems. For the medical sector, they provide clinical chemistry analyzers. Additionally, JEOL supplies industrial machinery crucial for thin-film deposition and material processing. Founded in Akishima, Japan, in 1949 as Japan Electron Optics Laboratory Co., Ltd., the company officially adopted its current name, JEOL Ltd., in 1961.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.86% | -2.01% | +8.43% | +2.69% | +41.84% | +31.36% | +62.11% | +65.97% | +25.74% | +623.63% | +512.41% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Hardware, Equipment & Parts: +10.0%-8.8% Q1'26: -17.9% (vs Q1'25)
-
EPS growth Hardware, Equipment & Parts: +20.2%+18.3% Q1'26: +471.3% (vs Q1'25)
-
FCF margin FCF growth · Hardware, Equipment & Parts: +27.1%+6.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Hardware, Equipment & Parts: +8.7%+14.5% ★ Q1'26: +9.3% (vs Q1'25)
-
ROIC Hardware, Equipment & Parts: +5.7%+14.7% ★ Q1'26: +13.3% (vs Q1'25)
-
Share dilution Hardware, Equipment & Parts: +0.0%-0.1% ★ Q1'26: -0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Hardware, Equipment & Parts: -0.70×0.86× Q1'26: 1.08× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 6 Rev. Ana. 5 EPS Ana. |
Mar 2027 4 Rev. Ana. 4 EPS Ana. |
Mar 2028 5 Rev. Ana. 5 EPS Ana. |
Mar 2029 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
95.38B
est: 99.22B (-3.9%)
|
107.37B
est: 103.50B (+3.7%)
|
99.70B
est: 99.03B (+0.7%)
|
104.57B
est: 102.21B (+2.3%)
|
111.29B
est: 109.52B (+1.6%)
|
117.24B
est: 119.96B (-2.3%)
|
110.44B
est: 110.09B (+0.3%)
|
138.41B
est: 137.14B (+0.9%)
|
162.69B
est: 157.20B (+3.5%)
|
174.34B
est: 182.02B (-4.2%)
|
196.70B
est: 196.14B (+0.3%)
|
181.82B
179.29B – 184.71B
-7.3% YoY
|
176.13B
169.54B – 184.68B
-3.1% YoY
|
189.52B
179.10B – 203.28B
+7.6% YoY
|
197.60B
197.10B – 198.10B
+4.3% YoY
|
| EBITDA |
7.08B
est: 14.81B (-52.2%)
|
9.48B
est: 15.44B (-38.7%)
|
5.53B
est: 14.78B (-62.6%)
|
8.06B
est: 15.25B (-47.2%)
|
10.79B
est: 16.34B (-34.0%)
|
11.17B
est: 17.90B (-37.6%)
|
9.99B
est: 16.43B (-39.2%)
|
21.11B
est: 20.46B (+3.2%)
|
28.71B
est: 23.46B (+22.4%)
|
34.31B
est: 34.12B (+0.5%)
|
30.26B
est: 36.77B (-17.7%)
|
34.08B
33.61B – 34.63B
-7.3% YoY
|
33.02B
31.78B – 34.62B
-3.1% YoY
|
35.53B
33.57B – 38.11B
+7.6% YoY
|
37.04B
36.95B – 37.14B
+4.3% YoY
|
| EBIT |
3.99B
est: 11.76B (-66.1%)
|
6.23B
est: 12.27B (-49.2%)
|
2.64B
est: 11.74B (-77.5%)
|
5.02B
est: 12.12B (-58.6%)
|
7.67B
est: 12.99B (-40.9%)
|
7.61B
est: 14.22B (-46.5%)
|
5.77B
est: 13.05B (-55.8%)
|
16.78B
est: 16.26B (+3.2%)
|
23.79B
est: 18.64B (+27.6%)
|
29.56B
est: 28.98B (+2.0%)
|
25.08B
est: 31.23B (-19.7%)
|
28.95B
28.54B – 29.41B
-7.3% YoY
|
28.04B
26.99B – 29.40B
-3.1% YoY
|
30.17B
28.51B – 32.36B
+7.6% YoY
|
31.46B
31.38B – 31.54B
+4.3% YoY
|
| Net Income |
1.99B
est: 3.12B (-36.3%)
|
4.09B
est: 4.17B (-2.0%)
|
595.00M
est: 389.51M (+52.8%)
|
4.53B
est: 4.03B (+12.4%)
|
5.94B
est: 5.28B (+12.5%)
|
5.36B
est: 5.68B (-5.7%)
|
3.75B
est: 4.76B (-21.4%)
|
12.28B
est: 11.53B (+6.5%)
|
17.83B
est: 18.09B (-1.4%)
|
21.70B
est: 23.88B (-9.1%)
|
18.69B
est: 25.75B (-27.4%)
|
19.87B
18.71B – 22.46B
-22.8% YoY
|
22.36B
22.15B – 22.57B
+12.5% YoY
|
25.47B
21.98B – 28.94B
+13.9% YoY
|
27.30B
26.90B – 30.91B
+7.2% YoY
|
| SGA |
25.32B
est: 23.06B (+9.8%)
|
26.46B
est: 24.06B (+10.0%)
|
25.83B
est: 23.02B (+12.2%)
|
26.78B
est: 23.76B (+12.7%)
|
27.84B
est: 25.46B (+9.4%)
|
29.12B
est: 27.88B (+4.4%)
|
28.30B
est: 25.59B (+10.6%)
|
31.24B
est: 31.88B (-2.0%)
|
36.44B
est: 36.54B (-0.3%)
|
39.74B
est: 41.88B (-5.1%)
|
42.98B
est: 45.13B (-4.8%)
|
41.83B
41.25B – 42.50B
-7.3% YoY
|
40.53B
39.01B – 42.49B
-3.1% YoY
|
43.61B
41.21B – 46.77B
+7.6% YoY
|
45.46B
45.35B – 45.58B
+4.3% YoY
|
| EPS |
37.15
est: 61.10 (-39.2%)
|
84.63
est: 81.60 (+3.7%)
|
12.31
est: 7.62 (+61.6%)
|
93.80
est: 78.90 (+18.9%)
|
122.95
est: 103.25 (+19.1%)
|
110.92
est: 111.15 (-0.2%)
|
77.51
est: 93.19 (-16.8%)
|
246.76
est: 225.56 (+9.4%)
|
349.32
est: 361.85 (-3.5%)
|
424.91
est: 467.39 (-9.1%)
|
365.55
est: 499.46 (-26.8%)
|
398.97
366.31 – 439.58
-20.1% YoY
|
438.96
433.68 – 441.83
+10.0% YoY
|
503.89
430.20 – 566.53
+14.8% YoY
|
560.56
526.57 – 605.11
+11.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Militia Long/Short Equity ETF ORR | 0.65% | 896.0K | 14.19% |
| 2 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.27% | 3.05M | 0.40% |
| 3 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.18% | 709.4K | 0.58% |
| 4 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.15% | 837.2K | 0.58% |
| 5 | iShares MSCI Japan Small-Cap ETF SCJ | 0.14% | 351.9K | 0.50% |
| 6 | Dimensional - International Small Cap ETF DFIS | 0.08% | 4.68M | 0.39% |
| 7 | Schwab Fundamental International Small Company Index ETF FNDC | 0.08% | 2.27M | 0.39% |
| 8 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.06% | 128.6K | 0.83% |
| 9 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.06% | 7.75M | 0.40% |
| 10 | WisdomTree International SmallCap Dividend Fund DLS | 0.05% | 529.1K | 0.58% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiro Kobayashi | Managing Executive Officer & Director | — | male |
| Chikato Teramoto | Executive Officer & Deputy Finance Officer | — | — |
| Izumi Oi | President, Chief Executive Officer & Chairman | — | male |
| Jun Nagatsuka | Managing Executive Officer& Corporate Planning Officer | — | — |
| Katsumoto Yaguchi | Senior Managing Executive Officer & Director | — | male |
| Kiyotaka Fujino | GM of Medical Devices Division & ME Business Division and Managing Executive Officer | — | — |
| Masayuki Kobayashi | Managing Executive Officer | — | — |
| Osamu Wakimoto | Managing Executive Officer and GM SE Technology Division & SE Business Unit | — | — |
| Shintaro Yazuka | Head of Production Division & Managing Executive Officer | — | male |
| Tadashi Komagata | Senior Managing Executive Officer & GM of SE Business Unit | — | — |
| Toshihiko Kanayama | GM of Corporate Strategy Office, Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6951.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
